RESEARCH-USE BIOSIMILAR ANTIBODY
Ficlatuzumab
Monoclonal antibody · IgG1
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion.
TARGETHGF
YMonoclonal antibody
CATALOGSC-BS-534
CATALOG NUMBERSC-BS-534
MOLECULAR WEIGHTApprox. 144.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion.
Ficlatuzumab is a recombinant research-use antibody directed against HGF.